Application of the Frye Standard to Medical Expert Testimony

This article addresses a recent decision of a New York state appellate court concerning the admissibility of expert medical testimony to establish causation in a case involving injuries allegedly incurred from treatment with a prescription medication. In <i>Zito v. Zabarsky</i>, 28 A.D.3d 42 (2d Dep't Jan. 24, 2006), the appellate court held that expert testimony that a plaintiff's injury was caused by a prescription medication was admissible when that testimony was based on a single case report indicating a link between the medication and the injury. The court's holding is inconsistent with other New York appellate decisions addressing the admissibility of expert testimony concerning medical causation and threatens to dilute New York's standard for making that assessment, and could have the same effect in other states that apply the same standard.

34 minute read November 28, 2006 at 01:27 PM
By
Steven Glickstein and Robert Grass
Application of the Frye Standard to Medical Expert Testimony

This article addresses a recent decision of a New York state appellate court concerning the admissibility of expert medical testimony to establish causation in a case involving injuries allegedly incurred from treatment with a prescription medication.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts
Subscribe Now

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

How Courts Interpret and Apply the Interplay Between the Bankruptcy Code and Medicare Program Act

The combination of increasing operating costs and uncertain government reimbursement funding continues to place health care providers under financial pressure, and in many cases, financial distress. Given the importance of Medicare/Medicaid funding of claims under provider agreements with the federal government, how courts interpret and apply the interplay between the Bankruptcy Code and Medicare Program Act determines the disposition of hundreds of millions of dollars of claims for reimbursement that support the health care system.

April 30, 2026

AI Transparency: Clear Explanations Matter More Than Disclosure

As AI becomes embedded in everyday business and legal operations, organizations are confronting a new expectation: simply disclosing AI use is no longer enough. A critical shift is taking place in the legal industry: transparency is no longer just about disclosure; it’s about comprehension.

April 30, 2026